• Profile
Close

Accuracy of transperineal targeted prostate biopsies, both visual-estimation and image-fusion for men needing a repeat biopsy in the PICTURE trial

The Journal of Urology Jul 20, 2018

Simmons LAM, et al. - Authors assessed the detection of clinically significant prostate cancer (csPCa) using MRI-targeted biopsies, and compared visual-estimation to image-fusion targeting, in patients requiring repeat prostate biopsies. In order to detect csPCa and reduce over-diagnosis of insignificant cancers, MRI-targeted biopsies are accurate. Findings suggested the requirement of both visual-estimation and image-fusion targeted biopsies to maximise detection.

Methods

  • Experts performed a prospective, ethics-committee approved, registered PICTURE trial which enrolled 249 consecutive patients (11th/January/2012-29th/January/2014).
  • The men who were included in this study underwent an mpMRI and were blinded to its results.
  • Transperineal template prostate mapping (TTPM) biopsies were done in all.
  • This was preceded by visual-estimation and image-fusion targeted biopsies in 200 with a lesion.
  • csPCa was defined as Gleason >/=4+3 and/or any grade of cancer length >/=6mm.
  • Other definitions of csPCa were also evaluated for the primary endpoint.

Results

  • Findings suggested that the mean (SD) age was 62.6 (7) years, median (IQR) PSA 7.17ng/ml (5.25, 10.09), mean primary lesion size 0.37cc (SD1.52), with mean 4.3 (SD2.3) targeted cores per lesion (visual-estimation and image-fusion combined) and mean 48.7 (SD12.3) TTPM-biopsy cores.
  • As per data, 97 (48.5%) cases of csPCa and 85 (42.5%) insignificant cancers were detected by TTPM-biopsies.
  • Overall, 81 (40.5%) csPCa and 63 (31.5%) insignificant cancers were detected by mpMRI-targeted biopsies.
  • Results demonstrated that 18 (9%) with csPCa on MRI-targeted biopsies were benign or clinically insignificant on TTPM-biopsy.
  • On TTPM-biopsy but not on MRI-targeted biopsies, 34 (17%) were detected with csPCa; approximately half of these were present in non-targeted areas.
  • In 53/169 (31.3%) and 48/169 (28.4%), csPCa was found with visual-estimation and image-fusion (McNemar’s test, p=0.5322).
  • Researchers noted that visual-estimation missed 23 (13.6%) csPCa detected by image-fusion; image-fusion missed 18 (10.8%) csPCa that visual-estimation detected.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay